New drugs in clinical development in Europe.
This article deals with new antitumor agents currently in Phase I or II evaluation in various European centers. Drugs reviewed in this article include Taxotere, Camptothecin analogues, CPT-11, and Topotecan. Rhizoxin, D1694, and Bryostatin are among other agents reviewed in this article.
Cassidy
J
J
Beatson Oncology Centre, Western Infirmary, Glasgow, United Kingdom.
Kaye
S B
SB
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives; D002986:Clinical Trials as Topic; D005060:Europe; D006801:Humans
D000970:Antineoplastic Agents; D002166:Camptothecin